Kuros Biosciences Ltd. (CSBTF)
26.00
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Kuros Biosciences Enterprise Value : 6.511M for June 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Molecular Partners AG | 51.68M |
| BeOne Medicines Ltd. | 24.64B |
| AC Immune SA | 142.21M |
| CRISPR Therapeutics AG | 3.307B |
| Idorsia Ltd. | 2.960B |
Enterprise Value Related Metrics
| Earnings Yield | 0.24% |
| Operating Earnings Yield | 0.86% |
| Normalized Earnings Yield | 0.2369 |